Hanss Robert, Bein Berthold, Francksen Helga, Scherkl Wiebke, Bauer Martin, Doerges Volker, Steinfath Markus, Scholz Jens, Tonner Peter H
Department of Anaesthesiology and Intensive Care Medicine, University-Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Anesthesiology. 2006 Apr;104(4):635-43. doi: 10.1097/00000542-200604000-00005.
Baseline low-to-high frequency ratio (LF/HF) of heart rate variability predicted hypotension after subarachnoid block (SAB). LF/HF-guided treatment of hypotension with vasopressors or colloids was investigated.
In 80 women scheduled to undergo cesarean delivery during SAB, LF/HF and systolic blood pressure (SBP) were analyzed. Patients were randomly assigned to a control group (n = 40) or a treatment group (n = 40). Control patients were assigned by their baseline LF/HF to one of two subgroups: LF/HF less than 2.5 or LF/HF greater than 2.5. Treatment patients with baseline LF/HF greater than 2.5 were treated with vasopressor infusion right after SAB (n = 20) or colloid prehydration until LF/HF decreased below 2.5 (n = 20). The incidences of hypotension (SBP < 80 mmHg) and hypertension (SBP > 140 mmHg) were investigated. LF/HF is presented as median and range, and SBP is presented as mean +/- SD.
Three of 17 control patients with low baseline LF/HF (1.7 [1.3/1.8]) demonstrated hypotension, and mean SBP remained stable (lowest SBP = 105 +/- 14 mmHg). In contrast, 20 of 23 control patients with high baseline LF/HF (3.8 [3.3/4.8]; P < 0.0001 vs. low baseline LF/HF) demonstrated hypotension after SAB: lowest SBP = 78 +/- 15 mmHg (P < 0.0001 vs. lowest SBP of control group with low baseline LF/HF). LF/HF-guided vasopressor therapy prevented hypotension in 19 of 20 patients: baseline SBP = 123 +/- 15 mmHg, lowest SBP = 116 +/- 17 mmHg. Mean prophylactic colloid infusion of 1,275 +/- 250 ml reduced elevated baseline LF/HF from 5.4 (4.1/7.5) to 1.3 (0.8/1.59) (P < 0.0001). Hypotension was prevented in 17 of 20 patients: baseline SBP = 115 +/- 13 mmHg, lowest SBP = 104 +/- 19 mmHg. No hypertensive episode was recognized.
LF/HF may be a tool to guide prophylactic therapy of patients at high risk for hypotension after SAB. Vasopressor therapy tended to be more effective compared with colloid prehydration.
蛛网膜下腔阻滞(SAB)后心率变异性的基线低频与高频比值(LF/HF)可预测低血压。本研究探讨了基于LF/HF指导使用血管升压药或胶体治疗低血压的效果。
选取80例行SAB剖宫产的女性,分析其LF/HF和收缩压(SBP)。患者随机分为对照组(n = 40)和治疗组(n = 40)。对照组患者根据其基线LF/HF分为两个亚组:LF/HF小于2.5或LF/HF大于2.5。基线LF/HF大于2.5的治疗组患者在SAB后立即接受血管升压药输注治疗(n = 20)或胶体预扩容治疗直至LF/HF降至2.5以下(n = 20)。观察低血压(SBP < 80 mmHg)和高血压(SBP > 140 mmHg)的发生率。LF/HF以中位数和范围表示,SBP以平均值±标准差表示。
17例基线LF/HF较低(1.7 [1.3/1.8])的对照组患者中有3例出现低血压,平均SBP保持稳定(最低SBP = 105 ± 14 mmHg)。相比之下,23例基线LF/HF较高(3.8 [3.3/4.8];与基线LF/HF较低者相比,P < 0.0001)的对照组患者在SAB后有20例出现低血压:最低SBP = 78 ± 15 mmHg(与基线LF/HF较低对照组患者的最低SBP相比,P < 0.0001)。基于LF/HF指导的血管升压药治疗可预防20例患者中的19例发生低血压:基线SBP = 123 ± 15 mmHg,最低SBP = 116 ± 17 mmHg。平均预防性输注胶体1275 ± 250 ml可使升高的基线LF/HF从5.4(4.1/7.5)降至1.3(0.8/1.59)(P < 0.0001)。20例患者中有17例预防了低血压:基线SBP = 115 ± 13 mmHg,最低SBP = 104 ± 19 mmHg。未发现高血压发作。
LF/HF可能是指导SAB后低血压高危患者预防性治疗的一种工具。与胶体预扩容相比,血管升压药治疗似乎更有效。